SCHEMBL6161505

SCHEMBL6161505

CCOc1ccc(CNC(=O)c2c[nH]c3c(c2=O)CCC3)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.47
KDM4E B2RXH2 4/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 4/20 0.41
MAPT P10636 6/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 4/20 0.38
USP2 O75604 3/20 0.38
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 2/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
DHODH Q02127 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163159 0.98 POLB (0.47) POLBKDM4EMEN1KMT2ATP53
SCHEMBL6161355 0.93 HTT (0.40) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL6162446 0.90 KDM4E (0.43) KDM4EMEN1KMT2AMAPTHPGD
SCHEMBL6162486 0.89 PDE4A (0.39) POLBKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL6162568 0.89 LMNA (0.43) POLBKDM4EMEN1KMT2ATP53
SCHEMBL6164858 0.87 PDE4A (0.39) POLBTP53MAPTPDE4APDE4B
SCHEMBL6162060 0.84 POLB (0.54) POLBKDM4EMEN1KMT2ATP53
SCHEMBL6161126 0.83 POLB (0.55) POLBKDM4EMEN1KMT2ATP53
SCHEMBL6160973 0.81 GABRP (0.46) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL6205420 0.79 POLB (0.69) POLBKDM4EMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed